Ischemia modified albumin in perinatology
Özet
Ischemia modified albumin is a novel marker of ischemia generated due to hypooxygenation and
increased hydroxyl free radicals in low pH. The molecule has been licenced for clinical use as an early
marker for acute coronary syndrome in cardiology. Since presence of ischemia might have serious and
sometimes devastating effects in perinatology, various researches have evaluated its value in different
clinical conditions. This narrative review aims to summarize the literature concerning the value of IMA in
perinatology and guide for further research.
